Cargando…
Atorvastatin as an adjuvant with betamethasone valerate reduces disease severity and cardiovascular risks in Psoriasis
OBJECTIVES: To evaluate the effect of Atorvastatin as an adjuvant with betamethasone valerate on disease severity and cardiovascular risks in chronic plaque type psoriatic patients. METHODS: It is an interventional study conducted in Pharmacology Department of BMSI, JPMC with the collaboration of De...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Professional Medical Publications
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5768853/ https://www.ncbi.nlm.nih.gov/pubmed/29492087 http://dx.doi.org/10.12669/pjms.336.14068 |